Izraēla - ivrits - Ministry of Health

דר מ.בורשטיין בעמ - לחות לעור

Izraēla - ivrits - Ministry of Health

ש.שוורץ באר שבע בעמ - חפיפת שיער

Izraēla - ivrits - Ministry of Health

קוסמופארם בעמ - מסיר לק

Izraēla - ivrits - Ministry of Health

זהר קוסמטיקס (מ.עו.פ) בעמ - מסיר לק

Izraēla - ivrits - Ministry of Health

gsk consumer healthcare, israel ltd - calcium carbonate; calcium lactate gluconate; colecalciferol - טבליה תוססת - calcium lactate gluconate 1358 mg; calcium carbonate 1050 mg; colecalciferol 4 mg - calcium lactate gluconate - calcium lactate gluconate - calcium and vitamin d supplement. calcium helps in the maintenance of bones and teeth. vitamin d helps in the absorption and use of calcium.

Izraēla - ivrits - Ministry of Health

csl behring ltd., israel - coagulation factor ii (human); coagulation factor ix (human- rfixfc); coagulation factor vii (human); coagulation factor x (human); protein c; protein s antigen - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ii (human) 200 - 480 iu; coagulation factor vii (human) 100 - 250 iu; coagulation factor ix (human- rfixfc) 200 - 310 iu; coagulation factor x (human) 220 - 600 iu; protein c 150 - 450 iu; protein s antigen 120 - 380 iu - coagulation factor ix, ii, vii and x in combination - coagulation factor ix, ii, vii and x in combination - -treatment and perioperative prophylaxis of bleedings in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required.

Izraēla - ivrits - Ministry of Health

glaxo smith kline (israel) ltd - lamivudine 100 mg - tablets - lamivudine - zeffix is indicated for the treatment of chronic hepatitis b associated with the evidence of hepatitis b viral (hbv) replication and active liver inflammation in adults and also in children and adolescents aged 2 to 17 years old.

Izraēla - ivrits - Ministry of Health

glaxo smith kline (israel) ltd - lamivudine - טבליה - lamivudine 100 mg - lamivudine - lamivudine - zeffix is indicated for the treatment of chronic hepatitis b associated with the evidence of hepatitis b viral (hbv) replication and active liver inflammation in adults and also in children and adolescents aged 2 to 17 years old.

Izraēla - ivrits - Ministry of Health

glaxo smith kline (israel) ltd - lamivudine - תמיסה (פומי) - lamivudine 5 mg/ml - lamivudine - lamivudine - zeffix is indicated for the treatment of chronic hepatitis b associated with the evidence of hepatitis b viral (hbv) replication and active liver inflammation in adults and also in children and adolescents aged 2 to 17 years old.

Izraēla - ivrits - Ministry of Health

abic marketing ltd, israel - lamivudine - טבליה - lamivudine 100 mg - lamivudine - lamivudine - lamivudine is indicated for the treatment of chronic hepatitis b associated with the evidence of hepatitis b viral (hbv) replication and active liver inflammation in aduls and also in children and adolescents aged 2 to 17 years old.